Argenx Nv Adr Stock Price Prediction

ARGX Stock  USD 605.92  9.18  1.54%   
The RSI of Argenx NV's the stock price is slightly above 64. This suggests that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Argenx, making its price go up or down.

Oversold Vs Overbought

64

 
Oversold
 
Overbought
The successful prediction of Argenx NV's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with argenx NV ADR, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Argenx NV's stock price prediction:
EPS Estimate Next Quarter
0.39
EPS Estimate Current Year
1.8386
EPS Estimate Next Year
8.4438
Wall Street Target Price
626.3451
EPS Estimate Current Quarter
0.03
Using Argenx NV hype-based prediction, you can estimate the value of argenx NV ADR from the perspective of Argenx NV response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Argenx NV to buy its stock at a price that has no basis in reality. In that case, they are not buying Argenx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Argenx NV after-hype prediction price

    
  USD 596.74  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Argenx NV Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
483.15485.14656.41
Details
Naive
Forecast
LowNextHigh
581.82583.81585.80
Details
23 Analysts
Consensus
LowTargetHigh
530.71583.20647.35
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.040.460.76
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Argenx NV. Your research has to be compared to or analyzed against Argenx NV's peers to derive any actionable benefits. When done correctly, Argenx NV's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in argenx NV ADR.

Argenx NV After-Hype Price Prediction Density Analysis

As far as predicting the price of Argenx NV at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Argenx NV or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Argenx NV, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Argenx NV Estimiated After-Hype Price Volatility

In the context of predicting Argenx NV's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Argenx NV's historical news coverage. Argenx NV's after-hype downside and upside margins for the prediction period are 594.75 and 598.73, respectively. We have considered Argenx NV's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
605.92
594.75
Downside
596.74
After-hype Price
598.73
Upside
Argenx NV is very steady at this time. Analysis and calculation of next after-hype price of argenx NV ADR is based on 3 months time horizon.

Argenx NV Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Argenx NV is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Argenx NV backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Argenx NV, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.27 
2.00
  1.95 
  0.30 
8 Events / Month
11 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
605.92
596.74
0.00 
27.62  
Notes

Argenx NV Hype Timeline

argenx NV ADR is presently traded for 605.92. The entity has historical hype elasticity of -1.95, and average elasticity to hype of competition of -0.3. Argenx is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 27.62%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.27%. %. The volatility of related hype on Argenx NV is about 178.85%, with the expected price after the next announcement by competition of 605.62. About 60.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.78. argenx NV ADR had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days.
Check out Argenx NV Basic Forecasting Models to cross-verify your projections.

Argenx NV Related Hype Analysis

Having access to credible news sources related to Argenx NV's direct competition is more important than ever and may enhance your ability to predict Argenx NV's future price movements. Getting to know how Argenx NV's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Argenx NV may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ISEEIVERIC Bio(0.03)10 per month 0.25  0.23  2.45 (1.52) 18.29 
BPMCBlueprint Medicines Corp(1.72)8 per month 2.58 (0.02) 4.90 (3.62) 14.28 
AMLXAmylyx Pharmaceuticals 0.02 11 per month 4.03  0.23  10.06 (6.13) 33.56 
KRTXKaruna Therapeutics 0.00 0 per month 1.67 (0.03) 3.38 (2.71) 10.01 
DAWNDay One Biopharmaceuticals 0.23 9 per month 0.00 (0.07) 3.84 (3.69) 11.44 
MRTXMirati Ther 0.00 0 per month 0.00 (0.17) 4.02 (4.07) 16.13 
TERNTerns Pharmaceuticals(0.02)10 per month 0.00 (0.1) 5.68 (5.96) 34.09 
APLSApellis Pharmaceuticals 2.68 9 per month 0.00 (0.20) 4.00 (5.17) 15.97 
LEGNLegend Biotech Corp 0.27 9 per month 0.00 (0.19) 4.29 (5.82) 17.18 
ZLABZai Lab(1.58)9 per month 3.45  0.14  6.26 (5.73) 25.60 
SGENSeagen Inc 0.00 0 per month 0.00 (0.17) 1.02 (0.89) 6.86 
ALNYAlnylam Pharmaceuticals 0.73 10 per month 0.00 (0.11) 2.91 (3.88) 13.26 
ASNDAscendis Pharma AS(2.73)11 per month 0.00 (0.07) 3.27 (3.56) 22.16 
PCVXVaxcyte(10.51)10 per month 2.22  0.03  3.16 (4.09) 42.81 
TVTXTravere Therapeutics(0.38)8 per month 1.94  0.25  11.58 (4.13) 23.97 
AKROAkero Therapeutics(1.61)7 per month 2.68  0.06  5.23 (4.45) 13.37 
BGNEBeiGene(4.36)8 per month 2.57 (0.04) 3.46 (4.40) 13.85 

Argenx NV Additional Predictive Modules

Most predictive techniques to examine Argenx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Argenx using various technical indicators. When you analyze Argenx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Argenx NV Predictive Indicators

The successful prediction of Argenx NV stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as argenx NV ADR, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Argenx NV based on analysis of Argenx NV hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Argenx NV's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Argenx NV's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding24.01246.39148.6109.24
PTB Ratio7.067.325.317.69

Story Coverage note for Argenx NV

The number of cover stories for Argenx NV depends on current market conditions and Argenx NV's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Argenx NV is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Argenx NV's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Argenx NV Short Properties

Argenx NV's future price predictability will typically decrease when Argenx NV's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of argenx NV ADR often depends not only on the future outlook of the potential Argenx NV's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Argenx NV's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding57.2 M
Cash And Short Term Investments3.2 B

Additional Tools for Argenx Stock Analysis

When running Argenx NV's price analysis, check to measure Argenx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argenx NV is operating at the current time. Most of Argenx NV's value examination focuses on studying past and present price action to predict the probability of Argenx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argenx NV's price. Additionally, you may evaluate how the addition of Argenx NV to your portfolios can decrease your overall portfolio volatility.